News

First sentence EN version

1. rindkopa

test ENG

The Latvian Medicines Verification Organization (LZVO) in the fourth issue of the Newsletter (January 2023) looks back at the year 2022 – the performance indicators of the LZVS in the 4th quarter of 2022 and the year as whole and highlights the current events of 2023.

Summarizing what was done in 2022 and outlining the plans for 2023, the European Medicines Verification Organisation (EMVO) in cooperation with the National Medicines Verification Organisations has published the EMVS Community Newsletter – 2022 Holiday Bulletin edition. In this bulletin, Inese Erdmane, Chairwoman of the Board at the Latvian Medicines Verification Organisation (LZVO), also talks about this year's achievements.

The European Medicines Verification Organization (EMVO) has launched a Newsletter, which introduces to the criteria that allow the identification of the "critical countries" of the system, tells about Romania's verification experience and other current issues of the system.